Takashi Tachibana Selected Research

Nephroureterectomy

4/2022

Patients with Non-Muscle Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Tachibana Research Topics

Disease

4	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2019 - 01/2018
3	Diabetes Mellitus 01/2017 - 08/2006
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2016 - 10/2012
3	Erectile Dysfunction 10/2009 - 08/2006
2	Retinal Degeneration 01/2018 - 01/2016
2	Inflammation (Inflammations) 01/2016 - 07/2015
2	Epiretinal Membrane (Epiretinal Membranes) 12/2015 - 02/2015
2	Headache (Headaches) 11/2006 - 08/2006
1	Non-Muscle Invasive Bladder Neoplasms 04/2022
1	Margins of Excision 03/2019
1	Ocular Hypertension (Glaucoma, Suspect) 01/2019
1	Trisomy 18 Syndrome 01/2019
1	Pierson syndrome 10/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2018
1	Retinal Detachment (Retinal Detachments) 03/2018
1	Myopia 01/2017
1	Ovarian Teratoma 01/2017
1	Asthma (Bronchial Asthma) 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2017
1	Urethral Neoplasms (Urethral Cancer) 07/2016
1	Vision Disorders (Hemeralopia) 12/2015
1	Paralysis (Palsy) 12/2014
1	Ovarian Epithelial Carcinoma 12/2013
1	Disease Progression 12/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2006

Drug/Important Bio-Agent (IBA)

5	Retinaldehyde (Retinal)IBA 01/2019 - 01/2016
3	Vardenafil Dihydrochloride (Levitra)FDA Link 10/2009 - 08/2006
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2006 - 08/2006
1	AntioxidantsIBA 10/2019
1	Oxidants (Oxidizing Agents)IBA 10/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Aspartic Acid (Aspartate)FDA Link 01/2019
1	Laminin (Merosin)IBA 10/2018
1	C-Reactive ProteinIBA 03/2018
1	SteroidsIBA 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	N-Methylaspartate (NMDA)IBA 01/2017
1	PeriostinIBA 02/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 07/2015
1	CytokinesIBA 07/2015
1	Interleukin-6 (Interleukin 6)IBA 07/2015
1	1-dodecylpyridoxal (PLD)IBA 12/2013
1	Carboplatin (JM8)FDA LinkGeneric 12/2013
1	liposomal doxorubicin (Doxil)FDA Link 12/2013
1	PlatinumIBA 12/2013
1	Erythropoietin FDA Link 10/2012
1	EndostatinsIBA 10/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2012
1	Pharmaceutical PreparationsIBA 11/2006
1	Phosphodiesterase 5 InhibitorsIBA 08/2006

Therapy/Procedure

6	Vitrectomy 03/2018 - 10/2012
2	Therapeutics 04/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 07/2016 - 12/2013
1	Nephroureterectomy 04/2022
1	Intravesical Administration 04/2022
1	Transurethral Resection of Bladder 04/2022
1	Prostatectomy (Retropubic Prostatectomy) 03/2019
1	Critical Care (Surgical Intensive Care) 01/2019
1	Lasers (Laser) 01/2018
1	Salpingo-oophorectomy 01/2017
1	Radiotherapy 07/2016
1	Conservative Treatment 12/2014